P

Psybio Therapeutics Corp
XTSX:PSYB

Watchlist Manager
Psybio Therapeutics Corp
XTSX:PSYB
Watchlist
Price: 0.01 CAD Market Closed
Market Cap: CA$839.3k

Net Margin

0%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
CA$0
/
$0

Peer Comparison

Country Company Market Cap Net
Margin
CA
Psybio Therapeutics Corp
XTSX:PSYB
809k CAD
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280.3B CNY
Loading...
DE
BioNTech SE
NASDAQ:BNTX
28.5B USD
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
22.5B USD
Loading...
US
Incyte Corp
NASDAQ:INCY
20.6B USD
Loading...
US
Moderna Inc
NASDAQ:MRNA
20.3B USD
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
20.3B USD
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Psybio Therapeutics Corp
Glance View

Market Cap
839.3k CAD
Industry
N/A

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-02-08. The firm is developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The firm is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry. The company has developed a technology platform that enables the generation of its formulation for its lead compound psilocybin, biosynthetic psilocybin, and other targeted tryptamines through a biosynthetic process using genetically modified bacteria through collaboration with Miami University-based in Oxford, Ohio. The firm utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

PSYB Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Back to Top